ImmunityBio (NASDAQ:IBRX) has been flagged by a screening process that combines two valuable investing approaches: the Mark Minervini Trend Template and a High Growth Momentum (HGM) rating filter. The Trend Template, developed by two-time U.S. Investing Champion Mark Minervini, is a systematic set of technical criteria designed to identify stocks in strong, sustainable uptrends. It focuses on moving average alignment, price relative to 52-week highs and lows, and relative strength. The HGM rating, meanwhile, evaluates a stock's fundamental momentum — looking at earnings and sales growth, acceleration, and estimate revisions. By requiring a stock to pass both screens, this method targets companies that are not only technically strong but also fundamentally accelerating, a combination that historically has preceded some of the biggest market winners.

Technical Alignment with the Trend Template

IMMUNITYBIO INC (NASDAQ:IBRX) currently satisfies all eight of the Trend Template's core conditions, placing it firmly in what Minervini calls "Stage 2" — a healthy, bullish uptrend. Here is how the numbers stack up:

• Current Price vs. 150-Day & 200-Day Moving Averages: At $9.44, the stock trades well above both its 150-day SMA ($6.40) and its 200-day SMA ($5.40). This confirms the long-term trend is positive.
• Moving Average Slopes: The 150-day SMA and the 200-day SMA are both clearly rising. The previous SMA(200) was $5.36, and it has now increased to $5.40, confirming an upward slope.
• Moving Average Alignment: The 50-day SMA ($7.68) is above both the 150-day and 200-day SMAs. The 150-day SMA is also above the 200-day SMA. This perfect alignment is a hallmark of a strong, sustained uptrend.
• 52-Week High and Low: The current price of $9.44 is 384% above its 52-week low of $1.95 (far exceeding the 30% minimum) and sits within 24% of its 52-week high of $12.43 (meeting the 25% threshold). This places it near the top of its yearly range, a key characteristic of leading stocks.
• Relative Strength: The ChartMill Relative Strength (CRS) score is an exceptional 97.8. This means IBRX is outperforming nearly 98% of all other stocks in the market, a clear sign of institutional demand.

High Growth Momentum Fundamentals

The Trend Template confirms the "what" (a strong stock), but the High Growth Momentum screen validates the "why" (a fundamentally accelerating business). Minervini’s strategy emphasizes that the biggest winners show strong, often accelerating, earnings and sales growth before their major price moves. IBRX exhibits these very characteristics:

Earnings Growth (EPS)

• EPS Growth (1Y TTM): 44.6% — Strong double-digit growth.
• EPS Growth (Q2Q): 46.7% — Accelerating growth in the most recent quarter.
• EPS Growth (1Y FY): 37.7% — Positive growth for the last full fiscal year.
• EPS Acceleration: Three of the last four quarters (Q-1, Q-2, Q-3) show accelerating EPS growth rates of 33.3%, 41.7%, and 50.0% respectively.
• Earnings Surprises: The company beat EPS estimates in 3 of the last 4 quarters, with an average beat of 18.2%. This is a strong vote of confidence from management.

Revenue Growth

• Revenue Growth (1Y TTM): A very large 351.5%.
• Revenue Growth (Q2Q): 167.6% — Massive year-over-year growth in the latest quarter.
• Revenue Growth (1Y FY): 668.3% for the last full fiscal year.
• Revenue Surprises: Also beat revenue estimates in 3 of the last 4 quarters.
• Acceleration: Revenue growth over the last three reported quarters (Q2Q) was 2423.9%, 425.1%, and 407.0%. While high, this shows the business is operating at a very large scale compared to a small base.

Key Takeaway: The company is not just profitable on paper; its earnings are accelerating, and its revenue is growing at a triple-digit percentage rate. This combination of strong technical trends and explosive fundamental growth is the sweet spot the Minervini method seeks.

ChartMill Technical Assessment

While the fundamentals and long-term trend are strong, the ChartMill technical report provides a detailed view for timing an entry. The stock earns a stellar Technical Rating of 9 out of 10, driven by its positive short and long-term trends, high relative strength, and strong volume.

However, the Setup Rating is only 3 out of 10. This indicates that the stock is currently "extended" — meaning it has risen quickly and is not forming a tight consolidation pattern. The report notes that price movement has been volatile lately.

• Support: The strongest support zone is between $7.66 and $7.81.
• Resistance: The next major resistance level is at $9.45, a level the stock is currently testing.

For investors following the Minervini playbook, this suggests that while IBRX is a top-tier candidate for a watchlist, it may be prudent to wait for a pullback or a consolidation to form before initiating a full position, allowing for a more favorable risk/reward entry point.

Find More Setups

This screen is designed to find stocks with the perfect blend of technical strength and fundamental momentum. To see a full, updated list of stocks that meet these rigorous criteria, you can run the screen yourself.

Click here to view the full list of High Growth Momentum + Trend Template results.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. Trading and investing in stocks involves risk, and you should consult with a qualified financial professional before making any investment decisions. Past performance is not a guarantee of future results.

Read full article here »